FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era

FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era

The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.